Hims & Hers Files 8-K Under 'Other Events'

Ticker: HIMS · Form: 8-K · Filed: Nov 17, 2025 · CIK: 1773751

Hims & Hers Health, Inc. 8-K Filing Summary
FieldDetail
CompanyHims & Hers Health, Inc. (HIMS)
Form Type8-K
Filed DateNov 17, 2025
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001, $250.0 million, $55.5 m, $100.0 million
Sentimentneutral

Sentiment: neutral

Topics: 8-K, filing-update

Related Tickers: HIMS

TL;DR

HIMS filed an 8-K for an 'Other Event' on Nov 13th. No major news yet.

AI Summary

Hims & Hers Health, Inc. filed an 8-K on November 17, 2025, reporting an event on November 13, 2025. The filing is categorized under 'Other Events' and does not specify any material agreements, acquisitions, or financial changes. The company, formerly known as Oaktree Acquisition Corp., is incorporated in Delaware.

Why It Matters

This filing indicates a routine or unspecified event for Hims & Hers Health, Inc., requiring disclosure but not immediately revealing significant business developments.

Risk Assessment

Risk Level: low — The filing is a standard 8-K under 'Other Events' without immediate disclosure of material financial or operational changes.

Key Players & Entities

  • Hims & Hers Health, Inc. (company) — Registrant
  • Oaktree Acquisition Corp. (company) — Former company name
  • November 13, 2025 (date) — Earliest event date
  • November 17, 2025 (date) — Filing date

FAQ

What specific event is reported under 'Other Events' in the 8-K filing?

The filing does not specify the nature of the 'Other Events' beyond its categorization.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on November 13, 2025.

What is the filing date of this 8-K for Hims & Hers Health, Inc.?

The 8-K was filed on November 17, 2025.

What was Hims & Hers Health, Inc. formerly known as?

Hims & Hers Health, Inc. was formerly known as Oaktree Acquisition Corp.

In which state is Hims & Hers Health, Inc. incorporated?

Hims & Hers Health, Inc. is incorporated in Delaware.

Filing Stats: 503 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2025-11-17 08:04:04

Key Financial Figures

  • $0.0001 — which registered Class A Common Stock, $0.0001 par value HIMS New York Stock Exchange
  • $250.0 million — which the Company may repurchase up to $250.0 million of its Class A common stock. The 2025 S
  • $55.5 m — its Class A common stock for a total of $55.5 million, fully utilizing the authorized c
  • $100.0 million — the authorized capacity under its prior $100.0 million repurchase program, which was effective

Filing Documents

01 Other Events

Item 8.01 Other Events On November 13, 2025, the Board of Directors of Hims & Hers Health, Inc. (the "Company") authorized and approved a new share repurchase program (the "2025 Share Repurchase Program") pursuant to which the Company may repurchase up to $250.0 million of its Class A common stock. The 2025 Share Repurchase Program expires on November 11, 2028. The Company intends to use the 2025 Share Repurchase Program to repurchase shares on a discretionary basis from time to time, subject to general business and market conditions and other investment opportunities, through open market purchases, privately negotiated transactions, Rule 10b5-1 plans or other means. The 2025 Share Repurchase Program may be suspended or discontinued at any time. From October 1, 2025 through November 7, 2025, the Company repurchased 1,334,572 shares of its Class A common stock for a total of $55.5 million, fully utilizing the authorized capacity under its prior $100.0 million repurchase program, which was effective beginning July 2024.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HIMS & HERS HEALTH, INC. Date: November 17, 2025 By : /s/ Oluyemi Okupe Oluyemi Okupe Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.